cholangiocarcinoma,carcinoma of gallbladder
Conditions
Interventions
Gold Standard:Gold standard: histopathological examination
Index test:Tumor marker:CA50,CA19-9,AFP,CEA
Sponsors
The First Affiliated Hospital of University of Science and Technology of China
Eligibility
Sex/Gender
Male
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: (1) patients of BTC, HCC, CHC were defined by histopathology; (2) patients receiving AFP, CA19-9, CEA, CA50 examinations; (3) patients receiving imaging examinations; (4) complete clinical data.
Exclusion criteria
Exclusion criteria: Exclusion criteria: (1) tumors that invade other sites or have distant metastases, such as lung cancer or bowel cancer; (2) Lack of tumor marker or imaging tests; (3) missing clinical data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| tumor marker;specificity;sensibility; | — |
Secondary
| Measure | Time frame |
|---|---|
| positive likelihood ratio;negative likelihood ratio; | — |
Countries
China
Contacts
Public ContactJi-Zhou Wang
University of Science and Technology of China, Hefei, Anhui Province, China
Outcome results
None listed